Effects of Whole Body Vibration (WBV) on Musculoskeletal System of Aged Women
VIBROS
2 other identifiers
interventional
225
1 country
1
Brief Summary
A controlled, non-randomized trial will be carried out in 240 postmenopausal women, aged 55-75 years, over a 18-month period. The group 1 received a physical intervention, consisting of whole body vibration (WBV) over 12 months followed by training arrest during 6 months. The group 2 served as sedentary control. WBV training is performed 2 or 3 times per week, with each session lasting 20 minutes. The training included light squats at 35-50 Hz and ended up by stretching and relaxation exercises at 50 Hz. Bone, muscle and postural evaluations will be performed at the beginning, 6, 12 and 18 months in each group with evaluation of bone micro-architectural trabecular and cortical compartments, at the weight bearing tibia and the non weight bearing radius. The primary outcome of the project is the pre, mid, and post evaluations of bone. Bone exploration included dual x-ray absorptiometry (DXA) and high resolution peripheral quantitative computed tomography (HR-pQCT). Bone Mass Density (BMD) will be evaluated by DXA at lumbar, femoral levels and humeral, macro and micro-architectures of the cortical and trabecular compartments will be evaluated in distal radius and tibia by HR-pQCT and bone markers will be analyzed longitudinally. The secondary aim is to assess muscle performance and proprioception. Finally will be assessed markers of cartilage degradation and synthesis, no study has been published on this tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 6, 2013
CompletedFirst Posted
Study publicly available on registry
November 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedAugust 10, 2015
August 1, 2015
5.3 years
November 6, 2013
August 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Trabecular bone volume at the femoral neck
bone densitometric parameters will be evaluated with DXA (dual x-ray absorptiometry)
12 month
Secondary Outcomes (2)
Serum bone markers
12 month
Bone cortical compartment at radius and tibia
12 month
Study Arms (2)
sedentary
SHAM COMPARATORNo intervention
Vibration
EXPERIMENTALSubjects in this group will be submitted to the WBV for 5 to 20 minutes, 2 or 3 times a week while 12 months. The training included light squats at 35-50 Hz and ended up by stretching and relaxation exercises.
Interventions
Eligibility Criteria
You may qualify if:
- Be sedentary (less than 2 hours physical activity of low intensity per week)
- Fracture risk Densitometry Risk factors (FRAX) index between 3 and 10%
- Consent form signed
You may not qualify if:
- Bone concomitant disease (such as Paget's disease, osteomalacia),
- Endocrinopathy defined on biological criteria (such as Cushing's disease, hyperparathyroidism, hyperthyroidism, hypogonadism),
- Smoking habits (more than 5 cigarettes per day), chronic alcoholism,
- Treatments received in the previous 6 months affecting bone metabolism such as anabolics, anti-osteoporotic treatment, corticosteroids.
- Having a prosthesis (femur and knee),or recently placed metal bouts or plates
- acute thrombotic problems,
- severe heart- and vascular diseases,
- recent injuries due to operation or polyclinical intervention,
- acute hernia, discopathy, spondylolysis,
- epilepsy,
- severe migraine,
- pacemaker,
- every neurodegenerative or neuromuscular disease,
- dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Saint-Etienne
Saint-Etienne, 42000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thierry THOMAS, MD PhD
CHU de Saint-Etienne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2013
First Posted
November 13, 2013
Study Start
April 1, 2010
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
August 10, 2015
Record last verified: 2015-08